| 1 | Lakes' state and abundance across the Tibetan Plateau显示文摘Understanding the changes in number and areal extent of lakes,as well as their abundance and size distribution is important for assessments of regional and global water resources,biogeochemical cycles,and changes in climate.In this study,changes in lake area greater than 1 km2are mapped using Landsat datasets,spanning the 1970s,1990,2000,and 2010.In addition,high-resolution images(GeoCover Landsat mosaic 2000,with a pixel size of 14.25 m)are used for the first time to map lakes as small as 0.001 km2across the entire Tibetan Plateau(TP).Results show that the numbers and areal extent of individual lakes[1 km2in size show a slight decrease between the 1970s and 1990,followed by a clear increase from 1990 to 2010.Ninety-nine new lakes are identified between the 1970s and 2010,71 of which are found between 1990 and 2010.This indicates the accelerated glacier melt and/or increased difference of precipitation minus evaporation since the 1990s.More than 80%of the lakes show an increase in their area between the 1970s and2010.The lake census,using 2000 imagery,shows that there are 32,843 lakes with a total area of 43,151.08±411.49 km2,which makes up 1.4%of the total area of the TP.Around 96%of all lakes are small,with an area\1 km2,while the 1,204 large lakes([1 km2)account for96%of the total lake area.The TP is subdivided into 12greater drainage basins,and of these the inner TP dominates in terms of the number of lakes(55.03%),the total area of lakes(66%),and lake density(0.026/km2compared to the mean,0.011/km2).A plot of lake abundance against size shows that the size distribution of lakes departs from a typical power-law distribution,but displays such a distribution at the mean elevation(4,715 m),with an r2value of 0.97 and a slope of-0.66.The slopes of the abundance-size equations from each of the 12 greater basins,and from all basins together,are larger than-1,supporting the inference that larger lakes,rather than the small lakes,contribute more to the total lake surface area across the TP.The lake inventory provided in this study,along with the assessment of lake size distribution,have important implications for estimates of water balance,for water resource management,and for lake area estimations in the TP. | Guoqing Zhang Tong Yao Hongjie Xie Kexiang Zhang Fujing Zhu | 2014 | Chinese Science Bulletin2014，59，24： | 33 |
| 2 | Josephin domain containing 2(JOSD2)promotes lung cancer by inhibiting LKB1(Liver kinase B1)activity显示文摘Non-small cell lung cancer(NSCLC)ranks as one of the leading causes of cancer-related deaths worldwide.Despite the prominence and effectiveness of kinase-target therapies in NSCLC treatment,these drugs are suitable for and beneficial to a mere~30%of NSCLC patients.Consequently,the need for novel strategies addressing NSCLC remains pressing.Deubiquitinases(DUBs),a group of diverse enzymes with well-defined catalytic sites that are frequently overactivated in cancers and associated with tumorigenesis and regarded as promising therapeutic targets.Nevertheless,the mechanisms by which DUBs promote NSCLC remain poorly understood.Through a global analysis of the 97 DUBs’contribution to NSCLC survival possibilities using The Cancer Genome Atlas(TCGA)database,we found that high expression of Josephin Domain-containing protein 2(JOSD2)predicted the poor prognosis of patients.Depletion of JOSD2 significantly impeded NSCLC growth in both cell/patient-derived xenografts in vivo.Mechanically,we found that JOSD2 restricts the kinase activity of LKB1,an important tumor suppressor generally inactivated in NSCLC,by removing K6-linked polyubiquitination,an action vital for maintaining the integrity of the LKB1-STRAD-MO25 complex.Notably,we identified the first small-molecule inhibitor of JOSD2,and observed that its pharmacological inhibition significantly arrested NSCLC proliferation in vitro/in vivo.Our findings highlight the vital role of JOSD2 in hindering LKB1 activity,underscoring the therapeutic potential of targeting JOSD2 in NSCLC,especially in those with inactivated LKB1,and presenting its inhibitors as a promising strategy for NSCLC treatment. | Tao Yuan Chenming Zeng Jiawei Liu Chenxi Zhao Fujing Ge Yuekang Li Meijia Qian Jiamin Du Weihua Wang Yonghao Li Yue Liu Xiaoyang Dai Jianya Zhou Xueqin Chen Shenglin Ma Hong Zhu Qiaojun He Bo Yang | 2024 | Signal Transduction and Targeted Therapy2024，9，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员